Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | cytoplasmic peptidase PepQ | 0.0028 | 0 | 0.5 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.0225 | 1 | 1 |
Loa Loa (eye worm) | gamma-secretase subunit aph-1 | 0.0158 | 0.6579 | 0.6579 |
Echinococcus multilocularis | methionyl aminopeptidase 2 | 0.0225 | 1 | 1 |
Onchocerca volvulus | Methionine aminopeptidase 2 homolog | 0.0225 | 1 | 1 |
Mycobacterium ulcerans | methionine aminopeptidase MapB | 0.0028 | 0 | 0.5 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapA (map) (peptidase M) (MetAP) | 0.0028 | 0 | 0.5 |
Brugia malayi | gamma-secretase subunit aph-1 | 0.0158 | 0.6579 | 0.6579 |
Plasmodium vivax | methionine aminopeptidase 2, putative | 0.0225 | 1 | 1 |
Trypanosoma cruzi | Aph-1 protein, putative | 0.0061 | 0.1698 | 0.1698 |
Wolbachia endosymbiont of Brugia malayi | Xaa-Pro aminopeptidase | 0.0028 | 0 | 0.5 |
Trypanosoma cruzi | Aph-1 protein, putative | 0.0061 | 0.1698 | 0.1698 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPB (MAP) (PEPTIDASE M) | 0.0028 | 0 | 0.5 |
Mycobacterium ulcerans | dipeptidase PepE | 0.0028 | 0 | 0.5 |
Mycobacterium tuberculosis | Dipeptidase PepE | 0.0028 | 0 | 0.5 |
Giardia lamblia | Methionine aminopeptidase | 0.0225 | 1 | 1 |
Entamoeba histolytica | methionine aminopeptidase, putative | 0.0225 | 1 | 1 |
Leishmania major | methionine aminopeptidase 2, putative | 0.0225 | 1 | 1 |
Toxoplasma gondii | methionine aminopeptidase 2, putative | 0.0225 | 1 | 1 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.0225 | 1 | 1 |
Echinococcus granulosus | gamma secretase subunit aph 1 | 0.0158 | 0.6579 | 0.6579 |
Chlamydia trachomatis | aminopeptidase P | 0.0028 | 0 | 0.5 |
Mycobacterium tuberculosis | Methionine aminopeptidase MapB (map) (peptidase M) | 0.0028 | 0 | 0.5 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.0225 | 1 | 1 |
Loa Loa (eye worm) | initiation factor 2-associated protein | 0.0225 | 1 | 1 |
Mycobacterium tuberculosis | Probable cytoplasmic peptidase PepQ | 0.0028 | 0 | 0.5 |
Plasmodium falciparum | methionine aminopeptidase 2 | 0.0225 | 1 | 1 |
Treponema pallidum | methionine aminopeptidase (map) | 0.0028 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0029 | 0.0059 | 0.0059 |
Trypanosoma brucei | Aph-1 protein, putative | 0.0061 | 0.1698 | 0.1698 |
Echinococcus multilocularis | gamma secretase subunit aph 1 | 0.0158 | 0.6579 | 0.6579 |
Mycobacterium ulcerans | aminopeptidase | 0.0028 | 0 | 0.5 |
Mycobacterium ulcerans | methionine aminopeptidase | 0.0028 | 0 | 0.5 |
Mycobacterium leprae | Probable cytoplasmic peptidase PepQ | 0.0028 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE METHIONINE AMINOPEPTIDASE MAPA (MAP) (PEPTIDASE M) (MetAP) | 0.0028 | 0 | 0.5 |
Trichomonas vaginalis | Clan MG, familly M24, aminopeptidase P-like metallopeptidase | 0.0225 | 1 | 1 |
Onchocerca volvulus | 0.009 | 0.3162 | 0.3162 | |
Trypanosoma brucei | metallo-peptidase, Clan MG, Family M24 | 0.0225 | 1 | 1 |
Schistosoma mansoni | gamma-secretase subunit aph-1 | 0.0158 | 0.6579 | 0.6579 |
Chlamydia trachomatis | methionine aminopeptidase | 0.0028 | 0 | 0.5 |
Treponema pallidum | aminopeptidase P | 0.0028 | 0 | 0.5 |
Mycobacterium ulcerans | dipeptidase | 0.0028 | 0 | 0.5 |
Trypanosoma brucei | methionine aminopeptidase 2, putative | 0.0225 | 1 | 1 |
Trypanosoma cruzi | metallo-peptidase, Clan MG, Family M24 | 0.0225 | 1 | 1 |
Schistosoma mansoni | methionyl aminopeptidase 2 (M24 family) | 0.0225 | 1 | 1 |
Trypanosoma cruzi | metallo-peptidase, Clan MG, Family M24 | 0.0225 | 1 | 1 |
Echinococcus granulosus | methionyl aminopeptidase 2 | 0.0225 | 1 | 1 |
Trypanosoma brucei | RNA helicase, putative | 0.0029 | 0.0059 | 0.0059 |
Wolbachia endosymbiont of Brugia malayi | methionine aminopeptidase | 0.0028 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 38 uM | Cytostatic activity against human HT1080 cells by MTT assay | ChEMBL. | 17804231 |
IC50 (functional) | = 38 uM | Cytostatic activity against human HT1080 cells by MTT assay | ChEMBL. | 17804231 |
IC50 (functional) | = 340 uM | Cytostatic activity against human CCRFCEM cells by MTT assay | ChEMBL. | 17804231 |
IC50 (functional) | = 340 uM | Cytostatic activity against human CCRFCEM cells by MTT assay | ChEMBL. | 17804231 |
IC50 (ADMET) | = 500 uM | Cytostatic activity against human WI38 cells MTT assay | ChEMBL. | 17804231 |
Survival (functional) | = 69 % | Cytostatic activity against human HT1080 cells assessed as relative percent survival at 25 uM by MTT assay | ChEMBL. | 17804231 |
Survival (functional) | = 69 % | Cytostatic activity against human HT1080 cells assessed as relative percent survival at 25 uM by MTT assay | ChEMBL. | 17804231 |
Survival (functional) | = 91 % | Cytostatic activity against human WI38 cells assessed as relative percent survival at 25 uM by MTT assay | ChEMBL. | 17804231 |
Survival (functional) | = 91 % | Cytostatic activity against human WI38 cells assessed as relative percent survival at 25 uM by MTT assay | ChEMBL. | 17804231 |
Survival (ADMET) | = 92 % | Cytostatic activity against human WI38 cells assessed as relative percent survival at 5 uM by MTT assay | ChEMBL. | 17804231 |
Survival (functional) | = 97 % | Cytostatic activity against human HT1080 cells assessed as relative percent survival at 5 uM by MTT assay | ChEMBL. | 17804231 |
Survival (functional) | = 97 % | Cytostatic activity against human HT1080 cells assessed as relative percent survival at 5 uM by MTT assay | ChEMBL. | 17804231 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.